Health Condition 1: P84- Other problems with newborn
Conditions
Interventions
Intervention1: zinc supplementation: Neonates will be allocated into two groups, the Zinc group and the Placebo group, by generating a random sequence using permutated blocks of 10 each. Allocation co
Sponsors
Dr Supreeth sv
Eligibility
Inclusion criteria
Inclusion criteria: All late preterm(=35weeks), term, post term neonates admitted with hyperbilirubinemia in phototherapy range.
Exclusion criteria
Exclusion criteria: Neonates with direct hyperbilirubinemia • Major gross congenital anomalies (gastrointerstinal malformations, heart defects, neural tube defects) and with identifiable genetic syndromes. • Preterm neonate(=35weeks), who are already started on zinc supplementation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of oral zinc on serum bilirubin levels in neonates with hyperbilirubinemia undergoing at phototherapy To correlate the effect of oral zinc and duration of phototherapy in neonates with hyperbilirubinemia undergoing phototherapy at baselineTimepoint: To evaluate the effect of oral zinc on serum bilirubin levels in neonates with hyperbilirubinemia undergoing at 5 daysphototherapy To correlate the effect of oral zinc and duration of phototherapy in neonates with hyperbilirubinemia undergoing phototherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| To correlate the effect of oral zinc & duration of phototherapy in neonates with hyperbilirubinemia undergoing phototherapy at 5 daysTimepoint: To correlate the effect of oral zinc & duration of phototherapy in neonates with hyperbilirubinemia undergoing phototherapy at 5 days | — |
Countries
India
Contacts
Public ContactDr Supreeth sv
Sri Devaraj urs medical college
Outcome results
None listed